| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939307754AGB9307754D0 (en) | 1993-04-15 | 1993-04-15 | Diagnostic probes and therapeutic products |
| PCT/EP1994/001183WO1994024308A1 (en) | 1993-04-15 | 1994-04-15 | Diagnostic probes and their use in detecting human chromosomal abnormalities |
| AU66788/94AAU6678894A (en) | 1993-04-15 | 1994-04-15 | Diagnostic probes and their use in detecting human chromosomal abnormalities |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939307754AGB9307754D0 (en) | 1993-04-15 | 1993-04-15 | Diagnostic probes and therapeutic products |
| Publication Number | Publication Date |
|---|---|
| GB9307754D0true GB9307754D0 (en) | 1993-06-02 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB939307754APendingGB9307754D0 (en) | 1993-04-15 | 1993-04-15 | Diagnostic probes and therapeutic products |
| Country | Link |
|---|---|
| AU (1) | AU6678894A (en) |
| GB (1) | GB9307754D0 (en) |
| WO (1) | WO1994024308A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9611255A (en)* | 1995-10-23 | 1999-12-28 | Imp Cancer Research Thecnology | nucleic acid, processes for determining a patient's susceptibility to cancer, for diagnosing cancer in a patient, for predicting the relative prospects for the particular appearance of cancer in a patient, for treating cancer and for determining the loss of heterozygosity in a tissue sample , system to detect the presence or absence of, or mutation, in the region of human chromosome 10, polypeptide, molecule and use of nucleic acid and a molecule. |
| US6287854B1 (en) | 1996-10-22 | 2001-09-11 | Imperial Cancer Research Technology Limited | Diagnosis of susceptibility to cancer and treatment thereof |
| EP0878552A1 (en) | 1997-05-13 | 1998-11-18 | Erasmus Universiteit Rotterdam | Molecular detection of chromosome aberrations |
| JP2002513587A (en) | 1998-05-04 | 2002-05-14 | ダコ エー エス | Methods and probes for detecting chromosomal abnormalities |
| WO2000055169A1 (en)* | 1999-03-15 | 2000-09-21 | Thomas Jefferson University | TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| ES2627059T3 (en) | 2007-08-03 | 2017-07-26 | The Ohio State University Research Foundation | Ultraconserved regions encoding RNAnc |
| CN102137927B (en) | 2007-10-26 | 2014-03-12 | 俄亥俄州立大学研究基金会 | Methods of identifying fragile histidine triad (Fhit) interactions and uses thereof |
| AU2009257410B2 (en) | 2008-06-11 | 2014-03-06 | Fudan University | Use of miR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy |
| CA2781547A1 (en) | 2009-11-23 | 2011-05-26 | The Ohio State University | Materials and methods useful for affecting tumor cell growth, migration and invasion |
| ES2606146T3 (en) | 2010-11-12 | 2017-03-22 | The Ohio State University Research Foundation | Methods related to microRNA-21 and repair of disappearance in colorectal cancer |
| AU2011329066B2 (en) | 2010-11-15 | 2017-03-09 | The Ohio State University Research Foundation | Controlled release mucoadhesive systems |
| JP2014530612A (en) | 2011-10-14 | 2014-11-20 | ジ・オハイオ・ステート・ユニバーシティ | Methods and materials for ovarian cancer |
| WO2013090556A1 (en) | 2011-12-13 | 2013-06-20 | The Ohio State University | Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis |
| WO2013110053A1 (en) | 2012-01-20 | 2013-07-25 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
| US20160296352A1 (en) | 2015-04-13 | 2016-10-13 | Cook Medical Technologies Llc | Axial lock and release stent deployment system |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05500302A (en)* | 1989-07-03 | 1993-01-28 | テンプル・ユニバーシティ | TCL-5 gene rearrangement associated with T-cell leukemia and melanoma |
| Publication number | Publication date |
|---|---|
| WO1994024308A1 (en) | 1994-10-27 |
| AU6678894A (en) | 1994-11-08 |
| Publication | Publication Date | Title |
|---|---|---|
| GB2277826B (en) | Surgical and/or clinical apparatus | |
| GB2283678B (en) | Cryosurgical catheter probe | |
| GB9415125D0 (en) | Surgical product and its use | |
| GB2276551B (en) | Electrosurgery monitor and apparatus | |
| GB2263974B (en) | Ultrasound imaging and catheters for use therein | |
| IL109545A0 (en) | Medical probe with stylets | |
| GB9307754D0 (en) | Diagnostic probes and therapeutic products | |
| AP9400630A0 (en) | Diagnostic device and method | |
| IL106037A0 (en) | Therapeutic and diagnostic methods based on neurotrophin-4-expression | |
| GB2279120B (en) | Slidable assemblies and probe elements | |
| GB9120768D0 (en) | Diagnostic and prognastic materials and methods | |
| ZA976547B (en) | Lipid-binding proteins and their therapeutic and diagnostic use | |
| AU5447194A (en) | Diagnostic reagents and their use in the detection of human herpesvirus 7 | |
| GB9616504D0 (en) | Therapeutic product and its use | |
| GB9317185D0 (en) | Diagnostic method and therapy | |
| GB9312182D0 (en) | Pain location and stimulation probe | |
| GB9201191D0 (en) | Diagnostic and therapeutic compounds | |
| ZA934284B (en) | Therapeutic and diagnostic methods based on neurotrophin-4 expression | |
| ZA923716B (en) | Therapeutic and diagnostic methods based on neurotrophin-4 expression | |
| GB9325494D0 (en) | Ultrasound probes | |
| GB9101435D0 (en) | Therapeutic and diagnostic compounds | |
| GB9101436D0 (en) | Diagnostic and therapeutic compounds | |
| GB9107172D0 (en) | Therapeutic and diagnostic compounds | |
| GB8927669D0 (en) | Diagnostic agents and methods | |
| GB9420878D0 (en) | Diagnostic method and probe |